Synonyms: Granocyte®
G-CSF is an approved drug
Compound class:
Endogenous peptide in human, mouse or rat
Comment: Lenograstim is a recombinant form of glycosylated granulocyte colony-stimulating factor, with exactly the same sequence and function as the endogenous peptide.
Species: Human
|
No information available. |
Summary of Clinical Use |
There is no information regarding approval of lenograstim on the US FDA website. This drug may be approved by other national approval agencies. This peptide was developed as a immonostimulatory drug to be used to improve the complete remission rate of older patients receiving chemotherapy for acute myeloid leukemia [1]. Treatment with the orally-active CXCR2 antagonist AZD5069 has been shown to shown to markedly increase serum G-CSF concentrations in healthy volunteers (NCT01480739) [2] and to also augment sputum expression of G-CSF in patients with more severe asthma (NCT01890148) [3]. |